|
Volumn 19, Issue 3, 2007, Pages 153-155
|
Effects of thymosin - α1 on cell immunity function in patients with septic shock
|
Author keywords
Natural killer cell; Septic shock; T lymphocyte subtype; Thymosin 1
|
Indexed keywords
ANTIBIOTIC AGENT;
CD3 ANTIGEN;
CD4 ANTIGEN;
THYMOSIN ALPHA1;
DRUG DERIVATIVE;
IMMUNOLOGICAL ADJUVANT;
THYMOSIN;
ARTICLE;
CD4 CD8 RATIO;
CELLULAR IMMUNITY;
CLINICAL ARTICLE;
CLINICAL EVALUATION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
HUMAN;
IMMUNOMODULATION;
LYMPHOCYTE COUNT;
NATURAL KILLER CELL;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
SCORING SYSTEM;
SEPTIC SHOCK;
T LYMPHOCYTE;
ADULT;
AGED;
FEMALE;
IMMUNOLOGY;
MALE;
MIDDLE AGED;
T LYMPHOCYTE SUBPOPULATION;
ADJUVANTS, IMMUNOLOGIC;
ADULT;
AGED;
FEMALE;
HUMANS;
KILLER CELLS, NATURAL;
MALE;
MIDDLE AGED;
PROGNOSIS;
SHOCK, SEPTIC;
T-LYMPHOCYTE SUBSETS;
THYMOSIN;
|
EID: 34047195992
PISSN: 10030603
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (12)
|